Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	53.39	72.9	76.68	108.91	77.83	63.56
Cash & Short-Term Investments	53.39	72.9	76.68	108.91	77.83	63.56
Cash Growth	-32.12%	-4.92%	-29.60%	39.93%	22.45%	586.84%
Prepaid Expenses	0.98	1.6	1.59	1.64	1.48	1.32
Restricted Cash	-	-	-	0.4	0.39	0.05
Other Current Assets	-	-	-	-	0.05	-
Total Current Assets	54.37	74.51	78.26	110.94	79.75	64.93
Property, Plant & Equipment	1.45	2.07	2.87	2.95	0.64	1.03
Other Long-Term Assets	0.33	0.32	0.31	0.3	-	0.44
Total Assets	56.15	76.9	81.45	114.19	80.39	66.4
Accounts Payable	6.22	7.57	7.95	10.13	5.54	4.34
Current Portion of Leases	0.61	0.58	0.54	0.5	0.31	0.43
Current Unearned Revenue	-	-	-	-	1	-
Total Current Liabilities	6.83	8.15	8.49	10.63	6.84	4.77
Long-Term Leases	0.53	0.99	1.57	2.08	0	0.31
Long-Term Unearned Revenue	35	35	35	35	-	-
Total Liabilities	42.37	44.14	45.07	47.71	6.84	5.08
Common Stock	0.03	0.03	0.03	0.03	0.02	0.02
Additional Paid-In Capital	417.53	408.55	373.93	355.22	329.27	292.28
Retained Earnings	-403.77	-375.83	-337.58	-288.77	-255.75	-230.97
Shareholders' Equity	13.78	32.76	36.38	66.48	73.55	61.32
Total Liabilities & Equity	56.15	76.9	81.45	114.19	80.39	66.4
Total Debt	1.14	1.57	2.11	2.58	0.31	0.74
Net Cash (Debt)	52.25	71.33	74.56	106.33	77.52	62.82
Net Cash Growth	-32.10%	-4.34%	-29.87%	37.16%	23.39%	702.73%
Net Cash Per Share	1.67	2.37	2.80	4.40	3.77	5.18
Filing Date Shares Outstanding	31.2	31.2	29.4	25.73	22.14	19.25
Total Common Shares Outstanding	31.2	31.2	27.63	25.67	22.14	17.53
Working Capital	47.53	66.36	69.77	100.31	72.91	60.16
Book Value Per Share	0.44	1.05	1.32	2.59	3.32	3.50
Tangible Book Value	13.78	32.76	36.38	66.48	73.55	61.32
Tangible Book Value Per Share	0.44	1.05	1.32	2.59	3.32	3.50
Machinery	-	1.26	1.24	1.09	0.68	0.6

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q